Abstract
Amidst to current Coronavirus infectious disease 2019 (COVID-19) pandemic, the international pharmaceutical federation stated that pharmacists being a part of the healthcare system had a crucial role in the management cycle of COVID-19 outbreak. The purpose of this study was to assess the knowledge, attitude and practice of community pharmacists, to snapshot their current preparedness and awareness regarding COVID-19. An online survey was conducted among a sample of 393 community pharmacists from two provinces; Punjab and Khyber-Pakhtunkhwa, Pakistan during a period of strict lockdown (10th to 30th April 2020). A validated (Cronbach alpha= 0.077) self-administered questionnaire comprised of five sections (Demographics, source of information, knowledge, attitude, and practice) was used for data collection. Logistic regression was applied to find potential factors associated with good knowledge, attitude, and practice by using SPSS version 21. Of total 393 participants, 71.5% (n=281) had good knowledge, 44% (n=175) had positive attitude and 57.3% (n=225) had good practice regarding COVID-19. Social media (45.29%, n=178) was reported as the main source to seek information regarding COVID-19. Results revealed that the age of ≥26 years, Ph.D. degree level, and good knowledge were the substantial determinants (P<0.05) of a good attitude. Similarly, community pharmacist who had an experience of >5 years, hold a Ph.D. degree, good knowledge and good attitude had higher odds of good practice compared to reference categories (P<0.05). The findings demonstrated that the majority of community pharmacists had good knowledge, but had a poor attitude and practice towards the COVID-19. This study also highlighted the disparity in some aspects of knowledge, attitude, and practice that must be addressed in future educational, awareness, and counselling programs.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was received for this study.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was carried out according to the declaration of Helsinki. This study was conducted in a strict locked down period and educational institutes were also closed; hence, the study protocol was approved by the ethical committee of the local teaching hospital (Reference number: 817/THQ/HR). The online questionnaire had a pre-face that describes the nature and purpose of the study and a consent part that ensures anonymity and voluntary participation of participants.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Current affiliation: Institute of Health Sciences, Department of Pharmacology (Pharmacovigilance), Cukurova University, Adana, Turkey.
Previous affiliation: Department of Pharmacy, Quaid-i-Azam University, Islamabad, Pakistan. ORCID: http://orcid.org/0000-0003-1365-548X.
Data Availability
All data available inside the manuscript
